These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15223240)

  • 1. Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice.
    Paul R; Angele B; Sporer B; Pfister HW; Koedel U
    J Neuroimmunol; 2004 Jul; 152(1-2):78-82. PubMed ID: 15223240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained lipopolysaccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system.
    Matute-Bello G; Winn RK; Martin TR; Liles WC
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):358-61. PubMed ID: 15013988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas- or FasL-deficient mice display an increased sensitivity to nitrobenzene-induced testicular germ cell apoptosis.
    Richburg JH; Nañez A
    Toxicol Lett; 2003 Mar; 139(1):1-10. PubMed ID: 12595153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Braley-Mullen H
    J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
    Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
    J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth.
    Sata M; Hirata Y; Nagai R
    Hypertens Res; 2002 Jul; 25(4):577-82. PubMed ID: 12358144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
    Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FasL-Fas interactions regulate neovascularization in the cornea.
    Stuart PM; Pan F; Plambeck S; Ferguson TA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):93-8. PubMed ID: 12506060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics.
    Alenzi FQ; Marley SB; Lewis JL; Chandrashekran A; Warrens AN; Goldman JM; Gordon MY
    Exp Hematol; 2002 Dec; 30(12):1428-35. PubMed ID: 12482505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
    Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
    Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
    Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis.
    Koedel U; Angele B; Rupprecht T; Wagner H; Roggenkamp A; Pfister HW; Kirschning CJ
    J Immunol; 2003 Jan; 170(1):438-44. PubMed ID: 12496429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice.
    Kovac AD; Grammig J; Mahlo J; Steiner B; Roth K; Nitsch R; Bechmann I
    Eur J Neurosci; 2002 Jul; 16(1):159-63. PubMed ID: 12153542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K; Bentley SA; Cohen PL
    Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors.
    Hohlbaum AM; Gregory MS; Ju ST; Marshak-Rothstein A
    J Immunol; 2001 Dec; 167(11):6217-24. PubMed ID: 11714783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased retinal neovascularization in Fas ligand-deficient mice.
    Davies MH; Eubanks JP; Powers MR
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen.
    Kezuka T; Streilein JW
    Immunology; 2000 Mar; 99(3):451-7. PubMed ID: 10712676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
    Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
    Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.